Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 474

1.

Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients.

Piché MÈ, Martin J, Cianflone K, Bastien M, Marceau S, Biron S, Hould FS, Poirier P.

Metabolism. 2014 Jan;63(1):79-86. doi: 10.1016/j.metabol.2013.09.004. Epub 2013 Oct 10.

PMID:
24120264
2.

Upregulation of plasma insulin-like growth factor binding protein 2 levels after biliopancreatic diversion in humans.

Li Z, Martin J, Poirier P, Caron-Cantin SM, Hould FS, Marceau S, Marceau P, Picard F.

Obesity (Silver Spring). 2012 Jul;20(7):1469-73. doi: 10.1038/oby.2012.90. Epub 2012 Apr 23.

3.

Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial.

Hedberg J, Sundbom M.

Surg Obes Relat Dis. 2012 May-Jun;8(3):338-43. doi: 10.1016/j.soard.2012.01.014. Epub 2012 Feb 1.

PMID:
22425057
4.

Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up.

Lubrano C, Cornoldi A, Pili M, Falcone S, Brandetti F, Fabbrini E, Ginanni-Corradini S, Eramo A, Marini M, Migliaccio S, Giancotti V, Badiali M, Falsetto N, Prossomariti G, Spera G.

Int J Obes Relat Metab Disord. 2004 Dec;28(12):1600-6.

PMID:
15543161
5.

Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.

Caron-Cantin SM, Martin J, Bastien M, Munkonda MN, Lu H, Cianflone K, Moustarah F, Biertho L, Marceau S, Hould FS, Bussières J, Poirier P.

Obes Surg. 2013 Nov;23(11):1806-14. doi: 10.1007/s11695-013-0952-9.

PMID:
23585024
6.

Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters.

Pontiroli AE, Laneri M, Veronelli A, Frigè F, Micheletto G, Folli F, Adami G, Scopinaro N.

Cardiovasc Diabetol. 2009 Jul 20;8:37. doi: 10.1186/1475-2840-8-37.

7.

Increased plasma magnesium concentrations 3 years after biliopancreatic diversion with duodenal switch.

Hedberg J, Haenni A.

Obes Surg. 2012 Nov;22(11):1708-13. doi: 10.1007/s11695-012-0709-x.

PMID:
22773141
8.

Laparoscopic sleeve gastrectomy reduces the predicted coronary heart disease risk and the vascular age in obese subjects.

Iancu M, Copăescu C, Şerban M, Ginghină C.

Chirurgia (Bucur). 2013 Sep-Oct;108(5):659-65.

9.

Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.

Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T.

Ann Intern Med. 2011 Sep 6;155(5):281-91. doi: 10.7326/0003-4819-155-5-201109060-00005.

PMID:
21893621
10.
11.

The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes.

Camerini GB, Papadia FS, Carlini F, Catalano M, Adami GF, Scopinaro N.

Surg Obes Relat Dis. 2016 Feb;12(2):345-9. doi: 10.1016/j.soard.2015.05.012. Epub 2015 May 28.

PMID:
26381876
12.

Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery.

de Luis D, Pacheco D, Conde R, Primo D, Aller R, Izaola O.

Ann Nutr Metab. 2012;61(1):70-3. doi: 10.1159/000339378. Epub 2012 Jul 26.

PMID:
22846622
14.

Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch.

St-Pierre DH, Martin J, Shimizu H, Tagaya Y, Tsuchiya T, Marceau S, Biertho L, Bastien M, Caron-Cantin SM, Simard S, Richard D, Cianflone K, Poirier P.

Peptides. 2016 Dec;86:6-12. doi: 10.1016/j.peptides.2016.09.014. Epub 2016 Sep 25. Review.

PMID:
27681383
15.

Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women.

Munkonda MN, Martin J, Poirier P, Carrington A, Biron S, Lebel S, Cianflone K.

Nutr Diabetes. 2012 Aug 20;2:e41. doi: 10.1038/nutd.2012.13.

16.

Cardiovascular risk factors in obese women and their first-degree relatives.

Saraç F, Ozgen AG, Yilmaz C, Tüzün M.

Anadolu Kardiyol Derg. 2007 Dec;7(4):371-7.

17.

Biliopancreatic diversion with transient gastroplasty and duodenal switch: long-term results of a multicentric study.

Pata G, Crea N, Di Betta E, Bruni O, Vassallo C, Mittempergher F.

Surgery. 2013 Mar;153(3):413-22. doi: 10.1016/j.surg.2012.06.039. Epub 2012 Nov 2.

PMID:
23122900
18.

Roux-en-Y divided gastric bypass results in the same weight loss as duodenal switch for morbid obesity.

Deveney CW, MacCabee D, Marlink K, Welker K, Davis J, McConnell DB.

Am J Surg. 2004 May;187(5):655-9.

PMID:
15135686
19.

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F.

Lancet. 2015 Sep 5;386(9997):964-73. doi: 10.1016/S0140-6736(15)00075-6.

PMID:
26369473
20.

Should biliopancreatic diversion with duodenal switch be done as single-stage procedure in patients with BMI > or = 50 kg/m2?

Topart P, Becouarn G, Ritz P.

Surg Obes Relat Dis. 2010 Jan-Feb;6(1):59-63. doi: 10.1016/j.soard.2009.04.016. Epub 2009 May 13.

PMID:
19640795

Supplemental Content

Support Center